|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 916.75 INR | -1.27% |
|
+7.13% | +3.70% |
| 13/02 | Fortis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
| 13/02 | Fortis Healthcare Dec-quarter Consol Net Profit 1.97 Billion Rupees | RE |
Projected Income Statement: Fortis Healthcare Limited
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 40,301 | 57,176 | 62,976 | 68,929 | 77,828 | 91,945 | 1,08,088 | 1,23,108 |
| Change | - | 41.87% | 10.14% | 9.45% | 12.91% | 18.14% | 17.56% | 13.9% |
| EBITDA 1 | 4,044 | 10,931 | 11,013 | 12,676 | 15,879 | 21,265 | 26,089 | 30,647 |
| Change | - | 170.28% | 0.75% | 15.1% | 25.27% | 33.91% | 22.69% | 17.47% |
| EBIT 1 | 1,138 | 7,923 | 7,856 | 9,251 | 12,023 | 17,116 | 21,760 | 26,136 |
| Change | - | 595.95% | -0.84% | 17.76% | 29.96% | 42.36% | 27.13% | 20.11% |
| Interest Paid 1 | -1,659 | -1,468 | -1,291 | -1,310 | -1,844 | -2,696 | -2,478 | -1,924 |
| Earnings before Tax (EBT) 1 | 432.9 | 9,878 | 8,137 | 8,580 | 10,070 | 15,202 | 19,658 | 24,555 |
| Change | - | 2,181.8% | -17.63% | 5.44% | 17.37% | 50.95% | 29.31% | 24.91% |
| Net income 1 | -1,098 | 5,551 | 5,887 | 6,011 | 7,742 | 11,203 | 14,558 | 18,099 |
| Change | - | 605.76% | 6.05% | 2.1% | 28.79% | 44.71% | 29.94% | 24.33% |
| Announcement Date | 29/05/21 | 25/05/22 | 23/05/23 | 23/05/24 | 20/05/25 | - | - | - |
1INR in Million
Estimates
Forecast Balance Sheet: Fortis Healthcare Limited
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 7,308 | 5,530 | 3,404 | 5,566 | 19,671 | 17,238 | 8,972 | -5,057 |
| Change | - | -24.33% | -38.44% | 63.51% | 253.41% | -12.37% | -47.95% | -156.36% |
| Announcement Date | 29/05/21 | 25/05/22 | 23/05/23 | 23/05/24 | 20/05/25 | - | - | - |
1INR in Million
Estimates
Cash Flow Forecast: Fortis Healthcare Limited
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 2,115 | 1,153 | 4,472 | 9,425 | 8,469 | 12,623 | 8,413 | 8,921 |
| Change | - | -45.51% | 287.99% | 110.73% | -10.14% | 49.05% | -33.35% | 6.04% |
| Free Cash Flow (FCF) 1 | 2,740 | 7,501 | 3,750 | 1,576 | 5,770 | 6,559 | 14,123 | 17,323 |
| Change | - | 173.8% | -50.01% | -57.97% | 266.09% | 13.67% | 115.33% | 22.65% |
| Announcement Date | 29/05/21 | 25/05/22 | 23/05/23 | 23/05/24 | 20/05/25 | - | - | - |
1INR in Million
Estimates
Forecast Financial Ratios: Fortis Healthcare Limited
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | 10.04% | 19.12% | 17.49% | 18.39% | 20.4% | 23.13% | 24.14% | 24.89% |
| EBIT Margin (%) | 2.82% | 13.86% | 12.47% | 13.42% | 15.45% | 18.62% | 20.13% | 21.23% |
| EBT Margin (%) | 1.07% | 17.28% | 12.92% | 12.45% | 12.94% | 16.53% | 18.19% | 19.95% |
| Net margin (%) | -2.72% | 9.71% | 9.35% | 8.72% | 9.95% | 12.18% | 13.47% | 14.7% |
| FCF margin (%) | 6.8% | 13.12% | 5.95% | 2.29% | 7.41% | 7.13% | 13.07% | 14.07% |
| FCF / Net Income (%) | -249.6% | 135.13% | 63.7% | 26.22% | 74.53% | 58.54% | 97.02% | 95.71% |
Profitability | ||||||||
| ROA | -0.98% | 4.82% | 4.84% | 4.67% | 5.74% | 6.56% | 7.46% | 9.25% |
| ROE | -1.72% | 9.03% | 8.77% | 8.07% | 9.34% | 11.61% | 13.51% | 14.89% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | 1.81x | 0.51x | 0.31x | 0.44x | 1.24x | 0.81x | 0.34x | - |
| Debt / Free cash flow | 2.67x | 0.74x | 0.91x | 3.53x | 3.41x | 2.63x | 0.64x | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 5.25% | 2.02% | 7.1% | 13.67% | 10.88% | 13.73% | 7.78% | 7.25% |
| CAPEX / EBITDA (%) | 52.3% | 10.55% | 40.61% | 74.35% | 53.34% | 59.36% | 32.25% | 29.11% |
| CAPEX / FCF (%) | 77.21% | 15.37% | 119.26% | 597.98% | 146.78% | 192.46% | 59.57% | 51.5% |
Items per share | ||||||||
| Cash flow per share 1 | - | 11.46 | 10.89 | 14.33 | 18.86 | 20.82 | 26.09 | 30.47 |
| Change | - | - | -4.93% | 31.52% | 31.64% | 10.39% | 25.31% | 16.79% |
| Dividend per Share 1 | - | - | 1 | 1 | 1 | 1.324 | 1.508 | 1.644 |
| Change | - | - | - | 0% | 0% | 32.4% | 13.86% | 9.04% |
| Book Value Per Share 1 | 81.06 | 81.84 | 95.93 | 101.5 | 118.1 | 132.4 | 150.6 | 173.8 |
| Change | - | 0.95% | 17.22% | 5.81% | 16.36% | 12.11% | 13.73% | 15.42% |
| EPS 1 | -1.45 | 7.35 | 7.8 | 7.93 | 10.26 | 14.75 | 19.32 | 24.1 |
| Change | - | 606.9% | 6.12% | 1.67% | 29.38% | 43.77% | 30.98% | 24.71% |
| Nbr of stocks (in thousands) | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 |
| Announcement Date | 29/05/21 | 25/05/22 | 23/05/23 | 23/05/24 | 20/05/25 | - | - | - |
1INR
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E ratio | 62.1x | 47.4x |
| PBR | 6.92x | 6.09x |
| EV / Sales | 7.71x | 6.49x |
| Yield | 0.14% | 0.16% |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
BUY
Number of Analysts
17
Last Close Price
916.75INR
Average target price
1,070.88INR
Spread / Average Target
+16.81%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FORTIS Stock
- Financials Fortis Healthcare Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















